Evaluation of 8-arylsulfanyl, 8-arylsulfoxyl, and 8-arylsulfonyl adenine derivatives as inhibitors of the heat shock protein 90 Journal Article
| Authors: | Llauger, L.; He, H.; Kim, J.; Aguirre, J.; Rosen, N.; Peters, U.; Davies, P.; Chiosis, G. |
| Article Title: | Evaluation of 8-arylsulfanyl, 8-arylsulfoxyl, and 8-arylsulfonyl adenine derivatives as inhibitors of the heat shock protein 90 |
| Abstract: | Hsp90 is a chaperone protein with important roles in maintaining transformation and in elevating the survival and growth potential of cancer cells. Currently there is an increasing interest in developing inhibitors of this protein as anticancer therapeutics. One of such inhibitors, the purine-scaffold class, has been reported to be potent and selective against Hsp90 both in vitro and in vivo models of cancer. Here, a series of 8-arylsulfanyl, -sulfoxyl, and -sulfonyl adenine members of the purine class was synthesized and evaluated as inhibitors of the chaperone. The structure-activity relationship and selectivity for tumor Hsp90 of compounds within the series is presented. Our results suggest that 8-arylsulfanyl adenine derivatives are good inhibitors of chaperone activity, whereas oxidation of the sulfides to sulfoxides or sulfones leads to compounds of decreased activity. The study identifies derivative 11v as the most potent Hsp90 inhibitor of the purine-scaffold series published to date (EC50 = 30 nM), and also as the compound of this class with highest selectivity for tumor vs normal cell Hsp90 (700 to 3000-fold). Most rewardingly, this work has allowed for the identification of Hsp90 inhibitors with selective affinities for Hsp90-client protein complexes, derivatives that may represent useful pharmacological tools in dissecting Hsp90-regulated processes. © 2005 American Chemical Society. |
| Keywords: | controlled study; unclassified drug; human cell; antineoplastic agents; animals; mice; gene overexpression; breast cancer; cell line; antineoplastic activity; cytotoxicity; drug potency; drug screening assays, antitumor; cell line, tumor; structure activity relation; structure-activity relationship; tumor cell; heat shock protein 90 inhibitor; heat shock protein 90; hsp90 heat-shock proteins; polarization; sulfones; purine; adenine; chaperone; binding, competitive; mitosis inhibition; kidney proximal tubule; adenine derivative; 8 sulfanyladenine derivative; 8 sulfonyladenine derivative; 8 sulfoxyladenine derivative; 9 (pent 4 ynyl) 8 (6 bromobenzo[1,3]dioxol 5 ylsulfanyl)adenine; sulfoxides |
| Journal Title: | Journal of Medicinal Chemistry |
| Volume: | 48 |
| Issue: | 8 |
| ISSN: | 0022-2623 |
| Publisher: | American Chemical Society |
| Date Published: | 2005-04-21 |
| Start Page: | 2892 |
| End Page: | 2905 |
| Language: | English |
| DOI: | 10.1021/jm049012b |
| PUBMED: | 15828828 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 82" - "Export Date: 24 October 2012" - "CODEN: JMCMA" - "Source: Scopus" |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work